Compare AEXA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEXA | LXRX |
|---|---|---|
| Founded | 2025 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 554.5M | 547.4M |
| IPO Year | N/A | 2000 |
| Metric | AEXA | LXRX |
|---|---|---|
| Price | $11.19 | $1.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.63 |
| AVG Volume (30 Days) | 145.5K | ★ 2.3M |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $10.49 | $0.32 |
| 52 Week High | $11.91 | $1.83 |
| Indicator | AEXA | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.39 | 66.31 |
| Support Level | $11.10 | $1.08 |
| Resistance Level | $11.25 | $1.83 |
| Average True Range (ATR) | 0.23 | 0.12 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 40.38 | 84.83 |
American Exceptionalism Acquisition Corp A is a blank check company.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.